Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant Bet v1, the major birch pollen antigen, in a murine model of type I allergy. - Wiedermann,U.; Jahn,S.B.; Bohle,B. (J Allergy Clin Immunol, 1999)